US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:APLS
Recent news which mentions NASDAQ:APLS
APLS Stock Earnings: Apellis Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
May 07, 2024
Tickers
APLS
Tags
Earnings Reports
Market News
NASDAQ:APLS
From
InvestorPlace
Apellis Pharmaceuticals stock has lost 40% in 2024: buy the dip?
April 30, 2024
Tickers
APLS
USA
Tags
Trading Ideas
World
NASDAQ:APLS
From
Invezz
Better Pharmaceutical Stock: Apellis or Novartis?
September 14, 2021
Tags
NASDAQ:APLS
NYSE:NVS
From
StockNews.com
APLS Stock: The Trial Results That Have Apellis Pharmaceuticals Plunging Today
September 10, 2021
Tickers
APLS
Tags
Today's Market
Market News
APLS
From
InvestorPlace